Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00497068 · ClinicalTrials.gov registry record · Phase 2
Tobacco Use in Opioid Agonist Treated Pregnant Women
A Phase 2 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 2
- Development phase
- 210
- Enrollment target
NCT00497068: Completed Phase 2 study, sponsored by Johns Hopkins University.
NCT00497068 is a Phase 2 study that has completed, run by Johns Hopkins University. The registered enrollment target is 210 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00497068, a Phase 2 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 210 participants
- Enrollment target
Study Summary
The primary objective of the proposed study is to evaluate the efficacy of tobacco abstinence-contingent voucher incentives versus non-tobacco abstinence-contingent incentives for reducing or eliminating tobacco use during pregnancy in methadone treated women. In addition, the impact that this intervention has in reducing the incidence and severity of methadone associated neonatal abstinence syndrome will also be examined.
Interventions
- BEHAVIORAL control
- BEHAVIORAL tobacco abstinent contingent
- BEHAVIORAL non-contingent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2005-01 |
| Est. Completion | 2010-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00497068
The ClinicalTrials.gov registry entry for NCT00497068 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 210 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which control is the first listed.
NCT00497068 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00497068 about?
NCT00497068 is a clinical study titled "Tobacco Use in Opioid Agonist Treated Pregnant Women". The primary objective of the proposed study is to evaluate the efficacy of tobacco abstinence-contingent voucher incentives versus non-tobacco abstinence-contingent incentives for reducing or eliminating tobacco use during pregnancy in methadone treated women. In addition, the impact that this inter...
What is the current status of trial NCT00497068?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 210 participants. The study started on 2005-01. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00497068?
The interventions under investigation include: control (BEHAVIORAL), tobacco abstinent contingent (BEHAVIORAL), non-contingent (BEHAVIORAL).
Who is sponsoring clinical trial NCT00497068?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.